Clinical Trial Update: Cymbalta for Depression as a Complication of Bereavement [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating duloxetine (Cymbalta) for depression related to bereavement; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Cymbalta (duloxetine)

Snippet

Sponsor: Jefferson Clinic, P.C. | Conditions: Depression, Bereavement | Phase 4 | Status: UNKNOWN